15th Jan 2019 11:56
LONDON (Alliance News) - Shares in NetScientific PLC slumped on Tuesday as it terminated its formal sales process, with no approaches made for its acquisition.
Shares in NetScientific fell 54% to 3.00 pence on Tuesday.
NetScientific commercialises intellectual property relating to healthcare, including diagnostic tests and new drug delivery methods. It is currently listed London's AIM market.
In November, the firm said it would conduct a strategic review, including the potential sale of the company or a de-listing from the London Stock Exchange.
In December, NetScientific said it had received "indications of interest", but at the end of the process, no approaches were made, and no discussions were initiated.
As a result, NetScientific is considering other options, including looking for additional funding, reducing the company's costs, or de-listing from AIM.
Related Shares:
Netscientific